Oncorus Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Oncorus conducts biotechnology research focused on intravenously delivered, self-amplifying RNA medicines for cancer. The aim is to reduce tumor burden while mobilizing multiple components of the immune system to enhance anti-tumor activity. This approach places the company in the broader field of RNA-based strategies for cancer therapy. Headquartered in Andover, Massachusetts, Oncorus is a small biotechnology firm serving the oncology landscape. Its work targets cancer patients by developing RNA-focused therapies intended to stimulate immune responses against tumors. Further information is available on the company’s website at https://oncorus.com.